Takeda Pharmaceutical Company Ltd (武田薬品工業株式会社 Takeda Yakuhin Kōgyō Kabushiki-gaisha) is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 30,000 employees worldwide and achieved 16.2 billion USD in revenue during the 2012 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.

Manufactures, marketes and imports, exports pharmaceutical drugs

Ascent Pediatrics, Inc. ("Ascent" or the "Company"), is a drug development and marketing company focused exclusively on the pediatric market. The Company's strategy is to address unmet medical needs of children through the development of differentiated, proprietary products based on approved compounds with well known clinical profiles.

Pulmotect, Inc. develops clinical stage, novel, pathogen-agnostic, inhaled compound for the prevention and early treatment of acute, severe viral and bacterial respiratory infections. It provides safe, broad-spectrum, fast-acting protection against bacterial pneumonia (including MRSA), influenza, fungal pneumonia, and Class A bioterror agents (including anthrax, tularemia, and plague). The company was founded by Brenton Scott and Magnus Hook in 2007 and is headquartered in Houston, TX.

Ascent Pharmaceuticals, Inc. is a private company headquartered in the United States that manufactures pharmaceutical products and generic drugs.

Corixa is a developer of immunotherapeutics with a commitment to treating and preventing autoimmune diseases, cancer and infectious diseases by understanding and directing the immune system. Having founded in 1994, the company conducted various preclinical development programs, including the BEXXAR® therapy and the MELACINE® vaccine. Corixa is focused on immunotherapeutic products and has a broad technology platform enabling both fully integrated vaccine design and the use of its separate, proprietary product components on a standalone basis. The company partners with numerous developers and marketers of pharmaceuticals, targeting products that are powered by Corixa™ technology with the goal of making its potential products available to patients around the world. Corixa was acquired by GlaxoSmithKline on 12 July 2005, and GSK had formerly made use of the Corixa's MPL adjuvant in some of their vaccines. The company ceased operations in March 2006.

Develops biopharmaceutical products that stimulate the immune system

CAVΛDIS™ is a Dutch biomedical company active in the field of cardiovascular risk assessment. They develop prognostic tests to identify patients at risk of cardiovascular and disease. The company identified several novel biomarkers predictive for cardiovascular events. It is their goal is to develop clinically meaningful risk stratification tools that will help personalize treatment and achieve better patient outcomes.

Kossan Sdn. Bhd., a subsidiary of Kossan Rubber Industries Bhd., is a Malaysian company that provides financial services. It was acquired by Kossan Rubber Industries Bhd. on October 29, 2010 for $0.00 million.

RES is an IT company that offers database applications, bespoke software development, application maintenance and data analysis for SMEs.

The Texas A&M University System creates a seamless pathway for students to earn an associate and bachelor’s degree in related fields

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Cangene is a fully integrated developer and manufacturer of immune therapeutics. Our first drug, WinRho® SDF, has been commercially available since 1980, and since then we have established a solid track record of developing and commercializing plasma-derived products that address multiple therapeutic areas. Our current product portfolio consists of purified, concentrated antibody preparations (hyperimmunes) with target applications in infectious disease, hematology, transplantation and biodefense. Four of our hyperimmune products are approved in the United States and/or Canada, and three products are included in the U.S. Strategic National Stockpile. We are committed to the safety and quality of our products, the service of our customers, and the interests of our shareholders.

Takeda California (TCAL) leverages technical strength in structure-based drug design, biologics, and gene expression analysis to efficiently generate potential new medicines aligned with Takeda’s global market strategies. The Company is located in San Diego, a premiere biotechnology community full of collaboration opportunities and growth potential. TCAL scientists invented Nesina, approved in multiple countries for the treatment of type 2 diabetes, and the staff has advanced multiple preclinical programs for the treatment of diabetes, obesity, cancer, and various immune and CNS disorders. The Company also hosts Takeda's proprietary bacTRAP technology, which provides a molecular atlas of gene expression with unprecedented cellular resolution to enable the discovery of new drug targets with selective mechanisms of action. TCAL strives to nurture employee development by providing a wide range of learning opportunities. Staff members are also highly engaged in community service, frequently organizing events in support of area schools, charitable foundations, and the environment.

Midori Anzen Co., Ltd. designs and manufactures safety gears and equipment. It produces and supplies safety shoes and helmets, office and industrial uniforms, and cleaning equipment. The firm also offers healthcare and medical equipment, electrical measuring devices, and leather shoes. The company was founded in June 1952 and is headquartered in Tokyo, Japan.

Sumitomo Rubber Industries, Ltd. engages in the manufacture and sale of automotive tires, aluminum wheels, and industrial rubber products. It operates through the following segments: Tires, Sports, and Industrial & Other Products. The Tires segment handles the manufacture and sale of tires and tubes for various vehicles and applications. The Sports segment manages the manufacture and sale of golf and tennis equipment, and other related sporting equipment. The Industrial & Other Products segment deals with the manufacture and sale of high performance rubber, lifestyle, infrastructure, and industrial products. It also covers licensing business and manages golf tournaments, tennis schools and offers golf courses. The company was founded in 1909 and is headquartered in Kobe, Japan.

Baoding Xuzhuo Biotechnology Co., Ltd., established on 2022-06-30, Business scope includes general items:Biotechnology Extension Services;Medical Research and Experimental Development;Natural science research and experimental development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology intermediary service;Class I medical device,Class II medical device,Wholesale of agricultural and sideline products,Retail and Online Sales;Purchase of primary agricultural products.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Disinfection equipment sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Research Corporation Technologies, Inc. provides investment related services. It operates as technology development company that typically invests in new technology platforms in life sciences, healthcare technology, biomedical, preclinical and clinical-stage therapeutics, devices, drugs, and diagnostics, medical devices, and biotech tools for gene expression and protein production with medical devices. The company was founded in 1987 and is headquartered in Tucson, AZ.